121 related articles for article (PubMed ID: 20422823)
1. Usefulness of laboratory data in estimation of Crohn's disease activity.
Zubcevic N; Mesihovic R; Zubcevic S
Med Arh; 2010; 64(1):33-6. PubMed ID: 20422823
[TBL] [Abstract][Full Text] [Related]
2. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
[TBL] [Abstract][Full Text] [Related]
3. Simple Enterographic Activity Score for Crohn's Disease: comparison with endoscopic, biochemical, and clinical findings.
Eder P; Katulska K; Lykowska-Szuber L; Stawczyk-Eder K; Krela-Kaźmierczak I; Linke K
Pol Arch Med Wewn; 2013; 123(7-8):378-85. PubMed ID: 23778300
[TBL] [Abstract][Full Text] [Related]
4. Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.
af Björkesten CG; Nieminen U; Turunen U; Arkkila P; Sipponen T; Färkkilä M
Scand J Gastroenterol; 2012 May; 47(5):528-37. PubMed ID: 22356594
[TBL] [Abstract][Full Text] [Related]
5. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of C-reactive protein with activity of Crohn's disease].
Yang CH; Chen XY; Yang F; Ran ZH; Liu WZ; Xiao SD
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1253-5. PubMed ID: 16796884
[TBL] [Abstract][Full Text] [Related]
7. [Mean platelet volume (MPV) in Crohn's disease patients].
Douda T; Bures J; Rejchrt S; Kopácová M; Pecka M; Malý J
Cas Lek Cesk; 2006; 145(11):870-3. PubMed ID: 17168422
[TBL] [Abstract][Full Text] [Related]
8. Correlation between levels of C-reactive protein and clinical activity in Crohn's disease.
Karoui S; Ouerdiane S; Serghini M; Jomni T; Kallel L; Fekih M; Boubaker J; Filali A
Dig Liver Dis; 2007 Nov; 39(11):1006-10. PubMed ID: 17889628
[TBL] [Abstract][Full Text] [Related]
9. [Value of alpha-1-antitrypsin and thrombocytes in the assessment of inflammatory activity in Crohn disease].
Tromm A; Hüppe D; Straub H; Krieg M; May B
Med Klin (Munich); 1992 Feb; 87(2):53-7. PubMed ID: 1542282
[TBL] [Abstract][Full Text] [Related]
10. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
Ciećko-Michalska I; Fedak D; Mach T
Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
[TBL] [Abstract][Full Text] [Related]
11. Plateletcrit: a sensitive biomarker for evaluating disease activity in Crohn's disease with low hs-CRP.
Tang J; Gao X; Zhi M; Zhou HM; Zhang M; Chen HW; Yang QF; Liang ZZ
J Dig Dis; 2015 Mar; 16(3):118-24. PubMed ID: 25565427
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn's disease severity.
Gao SQ; Huang LD; Dai RJ; Chen DD; Hu WJ; Shan YF
Int J Clin Exp Pathol; 2015; 8(11):14779-85. PubMed ID: 26823804
[TBL] [Abstract][Full Text] [Related]
13. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial.
Peyrin-Biroulet L; Reinisch W; Colombel JF; Mantzaris GJ; Kornbluth A; Diamond R; Rutgeerts P; Tang LK; Cornillie FJ; Sandborn WJ
Gut; 2014 Jan; 63(1):88-95. PubMed ID: 23974954
[TBL] [Abstract][Full Text] [Related]
14. A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.
Forbes GM; Sturm MJ; Leong RW; Sparrow MP; Segarajasingam D; Cummins AG; Phillips M; Herrmann RP
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):64-71. PubMed ID: 23872668
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of different laboratory tests and activity indices reflecting the inflammatory activity of Crohn's disease.
Tromm A; Tromm CD; Hüppe D; Schwegler U; Krieg M; May B
Scand J Gastroenterol; 1992 Sep; 27(9):774-8. PubMed ID: 1411285
[TBL] [Abstract][Full Text] [Related]
16. Slight increases in the disease activity index and platelet count imply the presence of active intestinal lesions in C-reactive protein-negative Crohn's disease patients.
Nakarai A; Kato J; Hiraoka S; Inokuchi T; Takei D; Morito Y; Akita M; Takahashi S; Hori K; Harada K; Okada H; Yamamoto K
Intern Med; 2014; 53(17):1905-11. PubMed ID: 25175121
[TBL] [Abstract][Full Text] [Related]
17. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
18. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.
Jones J; Loftus EV; Panaccione R; Chen LS; Peterson S; McConnell J; Baudhuin L; Hanson K; Feagan BG; Harmsen SW; Zinsmeister AR; Helou E; Sandborn WJ
Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1218-24. PubMed ID: 18799360
[TBL] [Abstract][Full Text] [Related]
19. The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome.
Lahiff C; Safaie P; Awais A; Akbari M; Gashin L; Sheth S; Lembo A; Leffler D; Moss AC; Cheifetz AS
Aliment Pharmacol Ther; 2013 Apr; 37(8):786-94. PubMed ID: 23432394
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
Niederau C; Backmerhoff F; Schumacher B; Niederau C
Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
